An invention patent product (ZL 2019 1 0493157.5) for specific diagnosis of markers of premature rupture of membranes and early labor in pregnant women's vaginal secretions. This immunodiagnostic product provides clinical evidence for diagnosing rupture of fetal membranes and predicting premature de...
Manufactured by
Anhui Huibang Biological Engineering Co., Ltd.
China
National high-tech enterprise established in 2013, specializing in precision medicine diagnostics. Product lines include diabetic nephropathy tests, maternal and child health diagnostics, cardiovascular disease markers, tumor markers, and monoclonal antibody raw materials. Holds over 40 national patents with total investment of 450 million RMB.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
AVE Science & Technology Co.,Ltd.
China · 1 relevant product
Ningbo Jiajia Jianjian Biotechnology Co., Ltd.
China · 1 relevant product
Bioperfectus
China · 2 relevant products
28 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 12 relevant matches
HOB Biotech Group Corp., Ltd. · China
In vitro diagnostic tests for assessing premature birth risk and related pregnancy complications. These tests help identify risk factors associated with early delivery. SFDA-approved diagnostic solutions.
Wuxi BioHermes Bio & Medical Technology Co., Ltd. · China
A diagnostic test kit designed to detect fetal fibronectin in cervical samples to assess preterm birth risk. The kit helps identify pseudo-threatened preterm birth and provides scientific measurement for comprehensive evaluation of fetal health. It uses advanced detection methodology to distinguish between threatened preterm labor and false positives, reducing unnecessary clinical interventions.
Atlas Link, Inc. · United States
A rapid diagnostic test for the detection of preterm premature rupture of membranes (PROM). The test is included in Atlas Link's fertility and pregnancy diagnostic portfolio and meets FDA and CE regulatory requirements.
9 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products